Prescription drug · ANDA
Teriparatide NDC 0093-1106
Teriparatide acetate 250 ug/mL · Injection, Solution · Subcutaneous · Teva Pharmaceuticals USA, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0093-1106-16 | 00093110616 | 1 SYRINGE in 1 CARTON (0093-1106-16) / 2.24 mL in 1 SYRINGEMarketed from Dec 18, 2023 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Teriparatide
- Generic name (nonproprietary)
- teriparatide
- Active ingredients
- Teriparatide acetate — 250 ug/mL
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 208569
- Marketing start
- Listing expires
- Other FDA classes
- Parathyroid Hormone (Chemical structure)
- Identifiers
- Product ID 0093-1106_5e3977c0-a361-494b-ac07-0426dda5bd36SPL ID 5e3977c0-a361-494b-ac07-0426dda5bd36SPL set ID d371f0f7-d492-4481-b360-051456d56d65RxCUI 1435115UNII 9959P4V12N
- Pharmacologic class
- Parathyroid Hormone Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400093110616followed by a unit qualifier and the quantityPackage 00093-1106-16. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Teriparatide Injection is indicated: For the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) or who have failed or are intolerant to other available osteoporosis therapy. In postmenopausal women with osteoporosis, Teriparatide Injection reduces the risk of vertebral and nonvertebral fractures. To increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture or who have failed or are intolerant to other available osteoporosis therapy. For the treatment of men and women with osteoporosis associated with sustained systemic glucocorticoi…
Excerpt only. Read the full label for complete information.